Tuesday, January 24, 2012

Health Canada Approval and Clinical New Milestones for Allegiance and Prime - Canada NewsWire (press release)

Health Canada approving and Clinical New Milestones for Allegiance and first Canada NewsWire (press release) The main drawback to other psoriasis and disease of the skin treatments is that greater efficacy comes with greater the irritation and broadside effects. Psorberine™ and Relieva™ have zero toxicity and irritancy. The Relieva™ with 20% Psoberibe™ will render a ... and more » Link To Article

No comments:

Post a Comment